新的联合治疗，以及他们以前在不合格的人群，包括儿童与静脉药物滥用者中的应用，是此次协商会议的主要依据。
New combination therapies and their application to previously ineligible groups, including children and intravenous drug users, were a major thrust of the conference.
新的联合治疗，以及他们以前在不合格的人群，包括儿童与静脉药物滥用者中的应用，是此次协商会议的主要依据。
New combination therapies and their application to previously ineligible groups, including children and intravenous drug users, were a major thrust of the conference.
应用推荐